Not that I understood. I thought their PR said the
Post# of 36537
https://storage.googleapis.com/wzukusers/user...7_2020.pdf
NuGenerex Immuno-Oncology has received the upfront licensing fee of $2.625 million
In exchange for the license and distribution exclusivity, Bintai has paid an up-front licensing fee
of $2.625 million and has committed to funding 100% of the commercial development costs for
the Ii-Key-CoV-2 vaccine including laboratory and pre-clinical work,